Speaker illustration

Doctor Dawid Miskowiec

Medical University of Lodz, Lodz (Poland)

Member of:

EAPCI

The reinvented old player - an antazoline is effective in pharmacological cardioversion of atrial fibrillation

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias e-posters

Thumbnail

Cinderella drug: an antazoline is effective in pharmacological cardioversion of atrial fibrillation - Single center experience

Event: EHRA 2021

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: ePoster session

Thumbnail

Early overexpression of miR-499 in non-ST elevation acute coronary syndromes predicts long-term risk of major adverse cardiac events

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Clinical

Session: Acute Coronary Syndromes ePosters

Thumbnail

Left atrial diameter as a simple parameter predicting the effectiveness of antazoline-based pharmacological approach to cardioversion of atrial fibrillation

Event: EuroEcho-Imaging 2018

Topic: Imaging of Arrhythmias

Session: HIT Poster session 3

Thumbnail

Aortic diameters are dependent on the bicuspid aortic valve phenotype and the degree of aortic stenosis - a systematic review, meta-analysis and meta-regression

Event: ESC CONGRESS 2017

Topic: Aortic valve disease

Session: Biomarkers and phenotype in aortic stenosis

Thumbnail

Elevated microRNA-499 level in early phase of non-ST elevation acute coronary syndromes predicts increased long-term risk of major adverse cardiac events.

Event: ESC CONGRESS 2017

Topic: Infarction acute phase non STEMI

Session: Acute cardiac care

Thumbnail

Diabetes as an independent predictor of left ventricular longitudinal strain reduction at rest and during dobutamine stress test in patients with significant coronary artery disease.

Event: ESC CONGRESS 2017

Topic: Angina pectoris stable

Session: Stable CAD

Thumbnail

Transesophageal echocardigoraphy under conscious sedation for guiding cryoballoon pulmonary vein isolation in paroxysmal atrial fibrillation - the safety and feasibility study

Event: EuroEcho-Imaging 2016

Topic: 2D TOE

Session: HIT Poster session 2

Thumbnail

The cardiac-enriched miRNAs plasma levels (miR-1, miR-133a, miR-499) reflect the impaired left ventricular systolic function and correlate with cardiac necrosis markers in early phase of NSTE-ACS

Event: EuroEcho-Imaging 2016

Topic: Myocardial infarction

Session: HIT Poster session 2

Thumbnail

MiR-1, miR-133a and miR-499 plasma levels correlate with cardiac necrosis markers and reflect the impaired left ventricular systolic function in early phase of acute coronary syndromes

Event: Acute Cardiovascular Care 2016

Topic: Non ST-elevation myocardial infarction - ACS

Session: Acute coronary syndrome - Non ST-elevation myocardial infarction

Thumbnail

This platform is supported by

logo Novo Nordisk